Project Grant R21HD114113

Award Date 9/11/24
Completion Date 8/31/26
Dollars Obligated $432K
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
This $1,555,000 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) will fund research to understand the cellular mechanisms regulating mitochondrial DNA (mtDNA) heteroplasmy and quality control. The research team at the University of Washington will use cutting-edge single-cell and ultra-high accuracy sequencing techniques to investigate how mitochondrial quality control processes influence...
This $150,000 Project Grant award from the National Science Foundation's (NSF) Integrative Activities program (CFDA 47.083) aims to enhance the natural repair mechanisms of mitochondrial DNA (mtDNA) by improving the targeting of key repair enzymes to mitochondria. The University of South Alabama, the grant recipient, will use a novel computational framework to re-engineer the mitochondrial localization signals of five DNA glycosylases that excise oxidized DNA damage, with the goal of improving...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $466,125.00 to New York University School of Medicine to elucidate the role of mitochondrial function in rasopathies. The research aims to analyze mitochondrial morphology and function, including enzymatic activities and oxygen consumption, in tissues from a rasopathy mouse model. It will...
The National Institute of General Medical Sciences (NIGMS) awarded a $420,000 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Albert Einstein College of Medicine in Bronx, NY. The grant, running from May 1, 2025 to March 31, 2030, supports research to identify the molecular mechanisms of mitochondrial dysfunction in pathological stress conditions. The research aims to discover novel pathways of mitochondrial damage independent of the mitochondrial...
This federal Project Grant award for $373,129, awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research to explore the role of mitophagy (the degradation of damaged mitochondria) in promoting tissue health and homeostasis. Specifically, the research aims to investigate the physiological functions of the two distinct forms of mitophagy - ubiquitin-dependent and receptor-dependent - in the...
This Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) supports the development of innovative in vivo animal models for studying mitochondrial DNA (mtDNA) diseases. The $629,508 award to the University of Texas at Austin, effective September 16, 2024 through August 31, 2028, aims to generate designer zebrafish models with specific mtDNA variants to enable new research approaches for diagnosing and treating these complex...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $498,000.00 to support the development of the first murine animal model and adeno-associated virus (AAV)-based gene therapy for mitochondrial diseases caused by mutations in the MTATP6 gene. The key objectives are to: Develop a novel mitochondria-targeting base editing technology to create a truncating...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) aims to develop treatments to remove deleterious mitochondrial DNA (mtDNA) mutations that contribute to aging and age-related diseases. The $146,922 award supports research at the University of Southern California to use genetic and molecular biology tools, along with sequencing techniques, to purge mammalian cells of mtDNA molecules carrying harmful mutations. The project will leverage a cell line...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $1,570,000.00 to Rutgers, The State University to conduct research on RNA-mediated chromatin regulation and transgenerational epigenetic inheritance in C. elegans. The key objectives of this 5-year project are to: 1) investigate the function and enzymology of the novel histone modification H3K23me3, which is involved...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA Program 93.859 (Biomedical Research and Research Training) provides $1,248,750 to the University of Connecticut Health Center (UCHC) for a project titled "Mechanistic Elucidation of Mitochondrial Stress Response in Human Cells." The research aims to comprehensively elucidate the molecular and cellular mechanisms of the mitochondrial stress response, spanning from stress sensing and...

This federal Project Grant award, valued at $431,750, was provided by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports research by Rutgers, The State University of New Jersey, to investigate the mechanistic impact of mutations in the mitochondrial Lon protease on mitochondrial DNA integrity and gene expression. The research employs patient-derived induced pluripotent stem cells to characterize differences in mitochondrial protein turnover, energetics, and cellular stress responses between wild-type and mutant Lon proteins. Additionally, the project will determine mitochondrial DNA binding by these proteins and analyze the biogenesis of mitochondrial RNA transcripts using advanced microscopy techniques. This research aims to provide new insights into the critical role of the Lon protease in regulating mitochondrial DNA maintenance, transcription, and translation, with broader implications for understanding common diseases like cancer, neurodegeneration, and cardiac dysfunction.

Generated 7/1/25, 4:27 AM